288 related articles for article (PubMed ID: 35727133)
41. CARD-BCL-10-MALT1 signalling in protective and pathological immunity.
Ruland J; Hartjes L
Nat Rev Immunol; 2019 Feb; 19(2):118-134. PubMed ID: 30467369
[TBL] [Abstract][Full Text] [Related]
42. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex.
Martin D; Galisteo R; Gutkind JS
J Biol Chem; 2009 Mar; 284(10):6038-42. PubMed ID: 19112107
[TBL] [Abstract][Full Text] [Related]
43. In vitro reconstitution of interactions in the CARD9 signalosome.
Park JH; Choi JY; Mustafa MF; Park HH
Mol Med Rep; 2017 Oct; 16(4):3910-3916. PubMed ID: 28765954
[TBL] [Abstract][Full Text] [Related]
44. The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
Lu HY; Bauman BM; Arjunaraja S; Dorjbal B; Milner JD; Snow AL; Turvey SE
Front Immunol; 2018; 9():2078. PubMed ID: 30283440
[TBL] [Abstract][Full Text] [Related]
45. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.
Oeckinghaus A; Wegener E; Welteke V; Ferch U; Arslan SC; Ruland J; Scheidereit C; Krappmann D
EMBO J; 2007 Nov; 26(22):4634-45. PubMed ID: 17948050
[TBL] [Abstract][Full Text] [Related]
46. Molecular architecture and regulation of BCL10-MALT1 filaments.
Schlauderer F; Seeholzer T; Desfosses A; Gehring T; Strauss M; Hopfner KP; Gutsche I; Krappmann D; Lammens K
Nat Commun; 2018 Oct; 9(1):4041. PubMed ID: 30279415
[TBL] [Abstract][Full Text] [Related]
47. AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation.
Schimmack G; Eitelhuber AC; Vincendeau M; Demski K; Shinohara H; Kurosaki T; Krappmann D
Cell Commun Signal; 2014 Jul; 12():49. PubMed ID: 25245034
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD protein.
Woo HN; Hong GS; Jun JI; Cho DH; Choi HW; Lee HJ; Chung CW; Kim IK; Jo DG; Pyo JO; Bertin J; Jung YK
FEBS Lett; 2004 Dec; 578(3):239-44. PubMed ID: 15637807
[TBL] [Abstract][Full Text] [Related]
49. BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.
Seeholzer T; Kurz S; Schlauderer F; Woods S; Gehring T; Widmann S; Lammens K; Krappmann D
Front Immunol; 2018; 9():2695. PubMed ID: 30515170
[TBL] [Abstract][Full Text] [Related]
50. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.
Douanne T; Chapelier S; Rottapel R; Gavard J; Bidère N
Cell Immunol; 2020 Jul; 353():104133. PubMed ID: 32450431
[TBL] [Abstract][Full Text] [Related]
51. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4.
Dong W; Liu Y; Peng J; Chen L; Zou T; Xiao H; Liu Z; Li W; Bu Y; Qi Y
J Biol Chem; 2006 Sep; 281(36):26029-40. PubMed ID: 16831874
[TBL] [Abstract][Full Text] [Related]
52. Defining the combinatorial space of PKC::CARD-CC signal transduction nodes.
Staal J; Driege Y; Haegman M; Kreike M; Iliaki S; Vanneste D; Lork M; Afonina IS; Braun H; Beyaert R
FEBS J; 2021 Mar; 288(5):1630-1647. PubMed ID: 32790937
[TBL] [Abstract][Full Text] [Related]
53. Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
Jost PJ; Weiss S; Ferch U; Gross O; Mak TW; Peschel C; Ruland J
J Immunol; 2007 Jan; 178(2):953-60. PubMed ID: 17202357
[TBL] [Abstract][Full Text] [Related]
54. Bcl10 links saturated fat overnutrition with hepatocellular NF-kB activation and insulin resistance.
Van Beek M; Oravecz-Wilson KI; Delekta PC; Gu S; Li X; Jin X; Apel IJ; Konkle KS; Feng Y; Teitelbaum DH; Ruland J; McAllister-Lucas LM; Lucas PC
Cell Rep; 2012 May; 1(5):444-52. PubMed ID: 22708078
[TBL] [Abstract][Full Text] [Related]
55. The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.
Qiao H; Liu Y; Veach RA; Wylezinski L; Hawiger J
J Biol Chem; 2014 Aug; 289(32):21973-83. PubMed ID: 24958727
[TBL] [Abstract][Full Text] [Related]
56. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
[TBL] [Abstract][Full Text] [Related]
57. B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.
Bhattacharyya S; Borthakur A; Tyagi S; Gill R; Chen ML; Dudeja PK; Tobacman JK
J Biol Chem; 2010 Jan; 285(1):522-30. PubMed ID: 19897484
[TBL] [Abstract][Full Text] [Related]
58. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
[TBL] [Abstract][Full Text] [Related]
59. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
[TBL] [Abstract][Full Text] [Related]
60. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
Sun L; Deng L; Ea CK; Xia ZP; Chen ZJ
Mol Cell; 2004 May; 14(3):289-301. PubMed ID: 15125833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
